Maintenance and preemptive therapy with ganciclovir for cytomegalovirus colitis with extremely high antigenemia in adult T-cell leukemia

Int J Hematol. 2009 Mar;89(2):249-250. doi: 10.1007/s12185-008-0245-6. Epub 2009 Jan 20.

Authors

Sumimasa Nagai^{1

2}, Masaki Toshima³, Kazuya Sato³, Masaki Mori³, Tadashi Nagai³, Kazuo Muroi³, Keiya Ozawa³

Affiliations

¹ Division of Hematology, Department of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 3290498, Japan. sunagai-tky@umin.ac.jp.
² Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. sunagai-tky@umin.ac.jp.
³ Division of Hematology, Department of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi, 3290498, Japan.

PMID: 19152101
DOI: 10.1007/s12185-008-0245-6

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antigens, Viral / blood
Antiviral Agents / therapeutic use
Colitis / drug therapy
Colitis / virology*
Cytomegalovirus Infections / drug therapy*
Female
Ganciclovir / therapeutic use*
Humans
Leukemia-Lymphoma, Adult T-Cell / complications*
Middle Aged

Substances

Antigens, Viral
Antiviral Agents
Ganciclovir